TickerFactsScreenerDevelopers

ALNYLAM PHARMACEUTICALS, INC. (ALNY) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2008: $202.12M2009: $177.97M2010: $158.23M2011: $118.00M2012: $134.05M2013: $270.35M2014: $936.27M2015: $1.26B2016: $920.22M2017: $1.77B2018: $1.30B2019: $1.44B2020: $1.02B2021: $588.20M2022: -$158.22M2023: -$220.64M2024: $67.09M2025: $789.18M$789.18M
2008Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$789.18M+1076.3%
2024$67.09M+130.4%
2023-$220.64M-39.5%
2022-$158.22M-126.9%
2021$588.20M-42.1%
2020$1.02B-29.4%
2019$1.44B+10.5%
2018$1.30B-26.3%
2017$1.77B+92.0%
2016$920.22M-27.2%
2015$1.26B+35.1%
2014$936.27M+246.3%
2013$270.35M+101.7%
2012$134.05M+13.6%
2011$118.00M-25.4%
2010$158.23M-11.1%
2009$177.97M-12.0%
2008$202.12M—